cisplatin, nivolumab
Nivolumab a hade tare da cisplatin da gemcitabine an amince da su ta USFDA don ciwon daji na urothelial wanda ba shi da tushe ko metastatic.
Maris 2024: Hukumar Abinci da Magunguna ta ba da izini don amfani da nivolumab (Opdivo, Kamfanin Bristol-Myers Squibb) tare da cisplatin da gemcitabine a matsayin farkon jiyya ga manya marasa lafiya da marasa lafiya.
Pembrolizumab, USFDA
Enfortumab vedotin-ejfv tare da pembrolizumab an amince da su daga USFDA don ci gaba na gida ko na ciwon daji na urothelial
Feb 2024: The Food and Drug Administration has sped up the approval process for two drugs, enfortumab vedotin-ejfv (Padcev, Astellas Pharma) and pembrolizumab (Keytruda, Merck). These drugs are meant to treat people with locally ..
Bristol Myers Squibb, Farashin-274, nivolumab, Abin al'ajabi, Carcinoma na Urothelial
FDA ta amince da Nivolumab don amfani dashi azaman adjuvant jiyya ga urothelial carcinoma
Agusta 2021: Hukumar Abinci da Magunguna ta amince da Nivolumab (Opdivo, Bristol-Myers Squibb Co.) don ƙarin kulawa ga marasa lafiya da urothelial carcinoma (UC) waɗanda ke cikin haɗarin sake komawa bayan rad ..
Astellas Pharma Amurka, NCT03474107, Padcev, Gwajin EV-301
FDA ta ba da enfortumab vedotin-ejfv don maganin ci gaban urothelial carcinoma na cikin gida ko metastatic
Agusta 2021: Enfortumab vedotin-ejfv (Padcev, Astellas Pharma US, Inc.), Nectin-4-antibody-antibody da microtubule inhibitor, Hukumar Abinci da Magunguna ta amince da marassa lafiyar marasa lafiya tare da shawara na gida ..
Samurai Inc, mUC, platinum-dauke da chemotherapy, shirin mai karɓar mutuwa-1, govitecan sacituzumab, Trodelvy, TAFIYA
Govitecan na Sacituzumab yana samun amincewa da sauri daga FDA don ciwon daji na urothelial
Agusta 2021: Hukumar Kula da Abinci da Magunguna ta Sacituzumab govitecan (Trodelvy, Immunomedics Inc.) ta ba da hanzarta amincewa ga marasa lafiya da ke da ci gaba a cikin gida ko ƙwayar cutar urothelial (mUC) waɗanda suka riga sun karɓi ..